Skinkure Acne Eraser Spot Treatment

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the topical treatment of acne. It is formulated as a clear gel that is applied directly to acne spots once to twice daily. This medication is suitable for use on all skin types.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleansed prior to application. The spot treatment should be applied directly onto the blemish, taking care to avoid the eye area. It is important to note that the treatment should not be rinsed off after application.

Contraindications

Use is contraindicated in patients with damaged or broken skin due to the potential for adverse effects and compromised healing. No other contraindications have been specified.

Warnings and Precautions

For external use only. This product should not be applied to damaged or broken skin to prevent adverse reactions and ensure safety.

When utilizing this product, it is imperative to avoid contact with the eyes. In the event of accidental eye exposure, the affected area should be rinsed thoroughly with water to mitigate irritation.

Healthcare professionals should advise patients to discontinue use and seek medical advice if a skin rash develops during treatment. This precaution is essential to address any potential allergic reactions or sensitivities.

In cases of ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay. Prompt action is critical to ensure patient safety and appropriate management of any potential toxicity.

Side Effects

Patients should be aware that this product is for external use only and should not be applied to damaged or broken skin. During use, it is important to avoid contact with the eyes; in the event of contact, the eyes should be rinsed with water immediately to remove the product.

Participants are advised to discontinue use and consult a healthcare professional if a skin rash occurs. Additionally, this product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Skinkure Acne Eraser Spot Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of Skinkure Acne Eraser Spot Treatment in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this treatment to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The safety of salicylic acid during pregnancy has not been established, and its use is contraindicated due to potential risks to the fetus. There is a recognized risk of teratogenic effects associated with the use of salicylic acid during pregnancy. Therefore, pregnant patients should avoid using products containing salicylic acid unless specifically directed by a healthcare professional.

Dosage modifications may be necessary for pregnant individuals, and it is advised that they consult a healthcare provider prior to use to ensure safety for both the mother and the developing fetus.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient circumstances when treating patients with renal impairment, as specific guidelines or recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management strategies.

Healthcare providers should ensure that patients are aware of the importance of timely reporting of any suspected overdosage to facilitate effective treatment and minimize risks.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that the product should not be applied to damaged or broken skin to prevent potential complications.

Patients should be instructed to discontinue use and consult a doctor if they experience any skin rash while using the product. Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes during application. In the event of accidental eye exposure, patients should rinse their eyes thoroughly with water to remove the product.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the product is topical. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Skinkure Acne Eraser Spot Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)